|
ZWINT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.949300004218E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.658800E-03 |
| Normal-vs-Stage2 |
1.089800E-01 |
| Normal-vs-Stage3 |
2.248300E-04 |
| Normal-vs-Stage4 |
1.664490E-02 |
| Stage1-vs-Stage2 |
6.934800E-01 |
| Stage1-vs-Stage3 |
3.280800E-03 |
| Stage1-vs-Stage4 |
5.588100E-02 |
| Stage2-vs-Stage3 |
1.202430E-01 |
| Stage2-vs-Stage4 |
2.304200E-01 |
| Stage3-vs-Stage4 |
9.510000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.7713999994905E-07 |
| Normal-vs-AfricanAmerican |
1.516650E-03 |
| Normal-vs-Asian |
1.305660E-02 |
| Caucasian-vs-AfricanAmerican |
3.584600E-01 |
| Caucasian-vs-Asian |
3.206000E-01 |
| AfricanAmerican-vs-Asian |
1.008840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.73497000000022E-05 |
| Normal-vs-Female |
2.14460000003136E-06 |
| Male-vs-Female |
9.877100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.297610E-03 |
| Normal-vs-Extreme_Weight |
7.879800E-03 |
| Normal-vs-Obese |
2.16339999999926E-05 |
| Normal-vs-Extreme_Obese |
5.091600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.615600E-01 |
| Normal_Weight-vs-Obese |
3.838600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.065200E-01 |
| Extreme_Weight-vs-Obese |
5.232500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.979400E-01 |
| Obese-vs-Extreme_Obese |
1.128200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.383300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.76200000034932E-07 |
| Normal-vs-Age(61-80Yrs) |
4.444000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.550950E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.874000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.831900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.441690E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.256000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.988000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.305800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.174240E-04 |
| Normal-VS-Type2 PRCC |
5.92440000000138E-05 |
| Normal-VS-KIRP CIMP |
3.335900E-03 |
| Normal-VS-Unclassified PRCC |
2.559000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.036980E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.981400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.747790E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.053700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.347200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.149900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.996440E-03 |
| Normal-vs-N1 |
5.8486999999996E-05 |
| Normal-vs-N2 |
3.106800E-01 |
| N0-vs-N1 |
6.104000E-03 |
| N0-vs-N2 |
4.739000E-01 |
| N1-vs-N2 |
9.198400E-01 |
|
|
